Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network Phase III Trial
Gary Hudes, Lawrence Einhorn, Eric Ross, Andrew Balsham, Patrick Loehrer, Harry Ramsey, John Sprandio, Michael Entmacher, William Dugan, Rafat Ansari, Frank Monaco, Mark Hanna, Bruce Roth
Dive into the research topics of 'Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network Phase III Trial'. Together they form a unique fingerprint.